Post-earnings recap
Reported
Thu, Apr 29, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Lemaitre Vascular's Q1 earnings report showed an EPS of $0.28, but the lack of revenue data and guidance left investors uncertain. The stock reacted slightly negatively, down 0.2%, indicating that investors may have been looking for more detailed financial insights. Overall, the company appears to be maintaining stability without major shifts in strategy.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.28 | N/A | +0.00% |
| Revenue | N/A | N/A | N/A |
Management's commentary was neutral, reflecting a steady approach to current operations. There was no indication of significant changes in strategy.
Management did not provide specific revenue figures or future guidance.
The company maintained a steady outlook despite the lack of detailed financial metrics.